Decplist Max Injection contains Diclofenac 75 mg and Paracetamol 225 mg, a combination analgesic and anti-inflammatory therapy designed for rapid relief of acute pain and inflammation. Diclofenac inhibits prostaglandin synthesis to reduce inflammation and swelling, while Paracetamol provides central analgesic action for effective pain control.
Clinically, this combination is indicated for postoperative pain, musculoskeletal pain, joint disorders, and acute inflammatory conditions. The synergistic action ensures faster pain relief and improved patient comfort compared to monotherapy.
The injection formulation ensures precise dosing, rapid onset of action, and consistent therapeutic outcomes, making it suitable for hospitals, surgical centers, emergency care units, and specialty clinics. Intravenous or intramuscular administration allows immediate pain control in acute scenarios.
Decplist Max Injection contributes to enhanced recovery, reduced inflammation, and improved patient mobility, making it a trusted choice for acute pain management. Its evidence-based combination ensures safety and efficacy under strict medical supervision.